Dione Rowe
Psychiatric/Mental Health · Winner, SDNPI 1174862924
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $91,865 of the $152,150 with a category attached, or 60.4%. Neurocrine Biosciences, Inc. accounts for 62.6% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $58,776, more than ten times the $4,516 reported in 2021. Among psychiatric/mental health clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 458 payments — averaging $332.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$95K
- Alkermes, Inc.$55K
- Otsuka America Pharmaceutical, Inc.$414
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$408
- AbbVie$291
- Johnson & Johnson$220
- plus $927 from 16 others
What the payments were for
- Consulting fees$27,98418%
- Speaking & faculty fees$91,86560%
- Travel & lodging$23,08615%
- Food & beverage$9,1656%
- Education$510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$152,150 in reported general payments places this provider in the 95th percentile of 77 psychiatric/mental health providers in South Dakota.
See all psychiatric/mental health providers in South Dakota →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 62 | $378,966 |
| AristadaAripiprazole Lauroxil | 71 | $208,239 |
| Invega SustennaPaliperidone Palmitate | 62 | $181,393 |
| NuplazidPimavanserin Tartrate | 13 | $63,184 |
| RexultiBrexpiprazole | 43 | $59,876 |
| VraylarCariprazine Hcl | 39 | $57,870 |
| Abilify MaintenaAripiprazole | 13 | $37,846 |
| LybalviOlanzapine/Samidorphan Malate | 23 | $36,496 |
| Lupron DepotLeuprolide Acetate | 12 | $20,314 |
| VivitrolNaltrexone Microspheres | 13 | $19,661 |
| TrintellixVortioxetine Hydrobromide | 46 | $19,030 |
| Clozapine | 81 | $3,391 |
| Divalproex Sodium | 42 | $2,278 |
| Olanzapine | 82 | $1,844 |
| Olanzapine OdtOlanzapine | 21 | $1,441 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $95,284 | $378,96662 claims |
| Alkermes, Inc.Aristada, Lybalvi, Vivitrol | $54,607 | $264,396107 claims |
| Johnson & JohnsonInvega Sustenna | $220 | $181,39362 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $414 | $97,72356 claims |
| AbbVieVraylar, Lupron Depot | $291 | $78,18551 claims |
| Acadia Pharmaceuticals IncNuplazid | $36 | $63,18413 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $27 | $19,03046 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 77 psychiatric/mental health providers in South Dakota.
Other psychiatric/mental health in Winner
- Amber MoodyWinner$343
- Jennifer ErdmanRapid City$6K
- Nichole JohnsonSioux Falls$5K
- Andria PetersenSioux Falls$5K
- Christina CoffieldSpearfish$5K
- Carrie DyllaWatertown$4K
- Josie RiesWatertown$4K
- Holly AhlersSioux Falls$4K
- Jessica KoupalBlackhawk$3K
- Amy NewstromRapid City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.